Summary
Lowering supersaturation with respect to struvite and carbonate apatite is the most important prophylactic measure in patients with infection-induced kidney stone disease. This is best achieved by combining culture-specific antibiotics with urinary acidification. Urinary infection with non-urease-producing Escherichia coli, probably promoting struvite particle formation, must be eradicated. Possible measures for improving urothelial anti-adherence properties or reducing bacterial adherence are discussed.
Similar content being viewed by others
References
Ackermann D, Baumann JM, Siegrist P (1990) Therapy with l-methionine: effects on urinary composition and on systemic acid-base behaviour. In: Vahlensieck W, Gasser G, Hesse A, Schoeneich G (eds) Proceedings of the 1st European Symposium on Urolithiasis. Excerpta Medica, Amsterdam, p 192
Bagley DH (1987) Pharmacologic treatment of infection stones. Urol Clin North Am 14:347
Grenabo L, Hedelin H, Pettersson S (1986) The inhibitory effect of human urine on urease-induced crystallization in vitro. J Urol 135:416
Grenabo L, Hedelin H, Pettersson S (1988) Adherence of ureaseinduced crystals to rat bladder epithelium. Urol Res 16:49
Griffith DP (1978) Struvite stones. Kidney Int 13:372
Griffith DP, Osborne CA (1987) Infection (urease) stones. Miner Electrolyte Metab 13:278
Griffith DP, Gleeson MJ (1989) Renal infections and stones. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 269
Griffith DP, Khonsari F, Skurnick JH, James KE, Veterans Administrations Cooperative Study Group (1988) A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal-cord injury patients. J Urol 140:318
Hedelin H, Bratell S, Grenabo L, Pettersson S (1989) The bacteriology of operated renal stones. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 291
Hedelin H, Grenabo L, Hugosson J, Larsson P, Pettersson S (1989) E. coli — a promoting factor in the development of phosphate stones? In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 289
Hedelin H, Grenabo L, Pettersson S (1990) The effects of fractionated human urine on urease-induced crystallization in vitro. Urol Res 18:35
Jarrar K, Graef V, Boedeker HR (1990) Acimethin therapy of the infection stone: results of a long term study. In: Vahlensieck W, Gasser G, Hesse A, Schoeneich G (eds) Proceedings of the 1st European Symposium on Urolithiasis. Excerpta Medica, Amsterdam, p 195
Kobashi K, Hase J, Uehara K (1962) Specific inhibition of urease by hydroxamic acid. Biochim Biophys Acta 65:380
Lerner SP, Gleeson MJ, Griffith DP (1989) Infection stones. J Urol 141:753
Lotz M, Zisman E, Bartter FC (1968) Evidence for a phosphorus depletion syndrome in man. N Engl J Med 278:409
Martelli A, Buli P, Brunocilla E (1982) Propionohydroxamic acid in infected renal stones. J Urol 128:1130
Martelli A, Buli P, Spatafora S (1986) Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones. Urology 28:373
Murphy FJ, Zelman S (1965) Ascorbic acid as a urinary acidifying agent: 1. Comparison with the ketogenic effect of fasting. J Urol 94:297
Murphy FJ, Zelman S, Mau W (1965) Ascorbic acid as a urinary acidifying agent: 2. Its adjunctive role in chronic urinary infection. J Urol 94:300
Orskov I, Orskov F, Birch-Andersen A (1980) Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae. Infect lmmun 27:657
Orskov I, Ferencz A, Orskov F (1980) Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet I:887
Parsons CL (1982) Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127:167
Parsons CL (1986) Pathogenesis of urinary tract infection: bacterial adherence, bladder defense mechanisms. Urol Clin North Am 13:563
Parsons CL, Mulholland SG (1987) Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol 138:513
Parsons CL, Stauffer C, Mulholland SG, Griffith DP (1984) Effect of ammonium on bacterial adherence to bladder transitional epithelium. J Urol 132:365
Pizzarelli F, Peacock M (1987) Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. Nephron 46:247
Sallis JD, Thomson R, Rees B, Shankar R (1988) Reduction of infection stones in rats by combined antibiotic and phosphocitrate therapy. J Urol 140:1063
Shorr E, Carter AC (1950) Aluminum gels in the management of renal phosphatic calculi. JAMA 144:1549
Silverblatt FJ (1974) Host-parasite interactions in the rat renal pelvis. J Exp Med 140:1696
Svanborg Edén C, Freter R, Hagberg L, Hull R, Hull S, Leffler H, Schoolnik G (1982) Inhibition of experimental ascending urinary tract infection by epithelial cell-surface receptor analogue. Nature 298:560
Westenfellner M, Ungemach G (1981) l-Methionin zur Ansäuerung des Urins. Therapiewoche 31:5197
Williams JJ, Rodman JS, Peterson CM (1984) A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 311:760
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hess, B. Prophylaxis of infection-induced kidney stone formation. Urol. Res. 18, S45–S48 (1990). https://doi.org/10.1007/BF00301528
Issue Date:
DOI: https://doi.org/10.1007/BF00301528